This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Global Pain Management Devices Industry

Table 4: World Population of People Aged 65+ Years (InMillion) for Years 2012, 2020 & 2050 (includes correspondingGraph/Chart) II-8Neuropathic Pain: A Highly Underserved Market II-8Oncologic Pain: Another Potential Market for Pain ManagementDevices II-9Reducing Risk of Infection: An Important Factor to Increasethe Adoption Rate of Implantable Devices II-9Emphasis on Reduced Hospital Stays Pushes Up Demand for PainManagement Devices II-9PNS: A Potential Lucrative Area for Developing Pain ManagementDevices II-10Reimbursement Policy Impacts the Uptake of Pain ManagementDevices II-10Product Complexity: A Cause of Concern II-11

3. MARKET OVERVIEW FOR SELECT PAIN MANAGEMENT DEVICES II-12Electrical Stimulators II-12Implantable Neurostimulation Devices: The Future of PainManagement? II-12Spinal Cord Stimulation (SCS): A Rapidly Evolving Market II-12Occipital Nerve Stimulation: An Untapped Market withPotential II-13Will TENS Continues to Register Favorable Growth? II-14Analgesia Infusion Pumps II-14Analgesia Infusion Pumps: Continue to Register FavorableGrowth II-14Smart Pump Technology: A Major Growth Driver II-15Equipment Recalls Cast a Long Shadow of Worry II-15Table 5: Global Market for Implantable Infusion Pumps byGeographic Region - US, Canada, Japan, Europe and Rest ofWorld Markets Independently Analyzed with Annual SalesFigures in Thousand Units for Years 2011, 2013, 2015 and2017 (includes corresponding Graph/Chart) II-16

4. PRODUCT OVERVIEW II-17What is Pain? II-17Types of Pain II-17Classification of Pain II-18Acute Pain II-18Chronic Pain II-18Pain Management: An Overview II-18Treatment of Pain II-19Pharmacologic Method II-19Non-Pharmacological Method II-19Invasive Procedures II-20Palliative Care II-20Alternative Methods II-21Acupuncture II-21Biofeedback II-21Bioelectromagnetic Therapy II-21Biomagnetism and Magnetotherapy II-22Guided Imagery II-22Manual/Massage Therapies II-22Aromatherapy Massage II-22Swedish Massage II-22Deep Tissue Massage II-22Neuromuscular Therapy II-23Myofascial Release II-23Manual Lymph Drainage II-23Cranial Sacral Therapy II-23Reflexology II-23Naturopathy II-24Relaxation Therapy II-24Transcendental Meditation II-24Pain Management Devices II-24Electrical Spinal Cord Stimulators II-24Electrical Stimulus Devices II-25Transcutaneous Electric Nerve Stimulators (TENS) II-25Portable (Ambulatory) Infusion Pumps II-25Patient-Controlled Analgesia Infusion Devices II-25Non-Electronic Ambulatory Infusion Pumps II-26Advantages & Disadvantages of Non-Electronic Pumps II-26Electronic Ambulatory Infusion Pumps II-26Nerve Block Infusion Pumps II-27Specialty Infusion Pumps II-27Implantable Infusion Pumps II-27Programmable Implantable Infusion Pumps II-27Constant Flow Implantable Infusion Pumps II-28

2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 -1.15%
FB $117.58 0.73%
GOOG $693.01 0.29%
TSLA $240.76 -2.81%
YHOO $36.60 0.03%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs